0.00Open0.09Pre Close0 Volume41 Open Interest79.00Strike Price0.00Turnover586.49%IV-0.18%PremiumDec 27, 2024Expiry Date0.23Intrinsic Value100Multiplier-5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.1413Delta0.1809Gamma875.22Leverage Ratio-54.7234Theta0.0000Rho-123.71Eff Leverage0.0005Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet